Vomiting: Clinical Trials

147 trials for Vomiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

147 completed. 147 Phase 3, 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3147Completed 147
Phase 217Completed 17

Follow Vomiting: new trials by email Literature Review of Vomiting trials Research Report on Vomiting

Trials (filtered) newest first · largest first

All 147 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients
Aprepitant 40mg, Placebo - Nausea and Vomiting, Postoperative, Prevention
Phase 3CompletedCentre hospitalier de l'Université de Montréal (CHUM)2602026-02-272026-08-27
Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Dexamedomedine, Dexamethasone - Postoperative Nausea and Vomiting
Phase 3CompletedPatel Hospital, Pakistan682025-06-012026-02-23
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
QLM2010 for injection;dexamethasone, fosaprepitant dimeglumine for injection;palonosetron hydrochloride injection;dexamethasone - Chemotherapy-Induced Nausea and Vomiting
Phase 3CompletedQilu Pharmaceutical Co., Ltd.6652025-01-032025-11-18
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
Aprepitant Injection - Gynecological Tumor, Ovarian Cancer
Phase 3CompletedSichuan Cancer Hospital and Research Institute1432024-05-312025-12-04
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Netupitant / Palonosetron Oral Capsule [Akynzeo], Olanzapine, Dexamethasone Oral - Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy
Phase 3CompletedFudan University6442024-05-012026-04-09
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets - Functional Dyspepsia
Phase 3CompletedAbbott5642024-02-282026-04-03
An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (Prospective Randomised Controlled Study)
ringer lactate (20ml/kg), Dextrose 10% - Postoperative Nausea and Vomiting (PONV)
Phase 3CompletedAin Shams University2042024-02-252025-02-26
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Aprepitant Injection, Aprepitant Injection Placebo - Postoperative Nausea and Vomiting
Phase 3CompletedQilu Pharmaceutical (Hainan) Co., Ltd.5182024-02-022025-04-23
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
Metoclopramide and Vitamin B6, Vitamin B6, Ondansetron - Vomiting
Phase 2 / Phase 3CompletedUniversity of Baghdad2502024-01-302024-04-30
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAcacia Pharma Ltd4532024-01-182025-06-25
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis
Phase 3CompletedVanda Pharmaceuticals172024-01-092026-10-19
Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy
At-night Dexamethasone, At-induction Dexamethasone - Postoperative Nausea and Vomiting, Postoperative Pain
Phase 2 / Phase 3CompletedMansoura University602023-10-082024-01-25
Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
normal Saline, Dexamethasone, Dexmedetomidine - Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting
Phase 3CompletedAl-Azhar University1202023-08-102025-06-18
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization
Phase 3CompletedJennifer Holder-Murray33952023-05-152026-05-28
Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV
5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone - Chemotherapy-induced Nausea and Vomiting
Phase 3CompletedXingchen Peng2752023-04-152025-06-04
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
Metoclopramide, Placebo - Upper Gastrointestinal Bleeding
Phase 3CompletedUniversidad Autonoma de Nuevo Leon502023-03-012024-10-09
Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy
Ondansetron 8mg, Gabapentin - Post Operative Nausea and Vomiting, Sleeve Gastrectomy
Phase 3CompletedTanta University1002022-10-012025-04-17
THRIVE Feasibility Trial
Anesthetic technique Propofol TIVA, Anesthetic technique inhaled agent - Surgery--Complications, Anesthesia Complication
Phase 3CompletedWashington University School of Medicine3002022-09-292023-11-24
Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery
Baclofen Tablets - Postoperative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 2 / Phase 3CompletedTanta University1002022-08-222025-04-22
Postoperative Analgesic Effectiveness of Bupivacaine With and Without Dexmedetomidine in Patients With Abdominal Surgery
bupivacaine wound infilteration, Bupivacaine plus dexmedetomidine wound infilteration - Post Operative Pain, Bradycardia
Phase 2 / Phase 3CompletedSahiwal medical college sahiwal642022-02-202024-08-01

Showing 20 of 147. Sign in to see all of them.

Narrower conditions

Nausea (62)  ·  Postoperative Nausea and Vomiting (48)  ·  Pain, Postoperative (10)  ·  Pain (9)  ·  Breast Neoplasms (6)  ·  Neoplasms (6)  ·  Diarrhea (5)  ·  Gastroparesis (5)  ·  Abdominal Pain (4)  ·  Uterine Cervical Neoplasms (4)  ·  Fever (3)  ·  Gastroenteritis (3)  ·  Hyperemesis Gravidarum (3)  ·  Hypotension (3)

Broader conditions

Pathological Conditions, Signs and Symptoms (147)  ·  Signs and Symptoms (147)  ·  Signs and Symptoms, Digestive (146)  ·  Pathologic Processes (54)  ·  Postoperative Complications (50)  ·  Nausea (42)  ·  Neurologic Manifestations (26)  ·  Neoplasms (19)  ·  Neoplasms by Site (19)  ·  Digestive System Diseases (16)  ·  Gastrointestinal Diseases (15)  ·  Pain (14)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Urogenital Diseases (8)

Interventions

Dexamethasone (47)  ·  Ondansetron (31)  ·  Aprepitant (23)  ·  Palonosetron (21)  ·  Granisetron (17)  ·  Olanzapine (11)  ·  Calcium Dobesilate (9)  ·  fosaprepitant (6)  ·  Gabapentin (5)  ·  Metoclopramide (5)  ·  Sodium Chloride (5)  ·  casopitant (5)  ·  netupitant, palosentron drug combination (5)  ·  Saline Solution (4)  ·  Acetaminophen (3)

Sponsors

Merck Sharp & Dohme LLC (11)  ·  Helsinn Healthcare SA (9)  ·  Acacia Pharma Ltd (6)  ·  GlaxoSmithKline (5)  ·  M.D. Anderson Cancer Center (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Charleston Laboratories, Inc (3)  ·  Tesaro, Inc. (3)  ·  All India Institute of Medical Sciences (2)  ·  Evoke Pharma (2)  ·  Gary Morrow (2)  ·  Heron Therapeutics (2)  ·  Instituto Mexicano del Seguro Social (2)  ·  NCIC Clinical Trials Group (2)  ·  Odense University Hospital (2)

Countries

United States (52)  ·  Germany (18)  ·  China (14)  ·  Canada (13)  ·  France (13)  ·  Hungary (10)  ·  Russia (10)  ·  Czechia (9)  ·  Egypt (9)  ·  Italy (9)  ·  Poland (9)  ·  Bulgaria (8)  ·  Ukraine (8)  ·  India (7)  ·  Argentina (6)

Top investigators

Dennis Vargo, MD (3)  ·  Alejandro Gonzalez-Ojeda, M.D., Ph.D. (2)  ·  A. Riaz, MD (1)  ·  Aldo Maina, M.D. (1)  ·  Alex Molassiotis, MD (1)  ·  Alex Sia (1)  ·  Alexander Binning, M.D. (1)  ·  Amal I. Melhem-Bertrandt, MD (1)  ·  Andrea Bezjak, MD, MSC, FRCPC (1)  ·  Arne Johan Norheim, MD Doctor phD (1)  ·  Auro del Giglio, phD (1)

Results publications

PMID 19775450, PMID 23062719, PMID 24276953, PMID 26272769, PMID 27410922, PMID 28285236, PMID 30968588, PMID 11030465, PMID 11773155, PMID 12145072, PMID 12377323, PMID 12562658, PMID 12736106, PMID 15680647, PMID 16198982, PMID 16436839, PMID 16849762, PMID 19135415, PMID 19428297, PMID 19568773, PMID 19805683, PMID 20692030, PMID 20692031, PMID 20835873, PMID 20843504, PMID 21182781, PMID 21383291, PMID 21436683, PMID 21465325, PMID 21851346, PMID 21872708, PMID 22024310, PMID 22141732, PMID 22286518, PMID 22546966, PMID 22915657, PMID 22972538, PMID 23041302, PMID 23244208, PMID 23510951, PMID 23598819, PMID 23811424, PMID 23887247, PMID 24015953, PMID 24438599, PMID 24684734, PMID 24882606, PMID 24911369, PMID 25037960, PMID 25052410

NIH funding

2014 (2), U10CA037420 (2), 2005 (1), 2009 (1), 2019 (1), U10CA031946 (1)